Speech-Language Pathologists in Huber Heights, OH Accepting Medicare

10 Speech-Language Pathologists found. Showing 1 - 10

Erika Schwartz, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 8895 Emeraldgate Dr, Huber Heights, OH 45424 Phone: 937-237-6375

Mrs. Julie Cox, MS/CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Rd, Huber Heights, OH 45424 Phone: 937-237-6300

Mrs. Jodi Petyak, M.S. CCC/SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6998 Breckenwood Dr, Huber Heights, OH 45424 Phone: 937-681-1484

Kay Brookey, M.ED Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Rd, Huber Heights, OH 45424 Phone: 937-237-6300

Valerie Smith, M.ED., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Rd, Huber Heights, OH 45424 Phone: 937-237-6300

Mrs. Katherine Sullivan Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6061 Old Troy Pike, Huber Heights, OH 45424 Phone: 937-237-6350

Mrs. Kelly Ann Peltier, MA CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Rd, Huber Heights, OH 45424 Phone: 937-237-6300    Fax: 937-237-6307

Mrs. Stephanie D. Whitlow, MA, CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Road, Huber Heights, OH 45424 Phone: 937-237-6300

Shereen Berning Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 6061 Troy Pike, Huber Heights, OH 45424 Phone: 937-237-6350

Kelly Anne Tanner, M.A., CCC-SLP Speech-Language Pathologist Medicare: Not Enrolled in Medicare Practice Location: 5954 Longford Rd, Huber Heights, OH 45424 Phone: 937-237-6300

News Archive

Novel Structure Proteins (NSP) could help predict the possibility of tumor growth in a patient

A new family of genes called Novel Structure Proteins (NSP) discovered by researchers in the Sbarro Institute for Cancer Research and Molecular Medicine in Temple University's College of Science and Technology could have the potential for predicting the possibility of tumor growth in a patient.

PACTR: The first WHO endorsed trials registry in Africa

The Pan-African Clinical Trials Registry (PACTR) has been accepted as a primary clinical trials registry - the first World Health Organization (WHO) endorsed trials registry in Africa. This registry will feed data into the global WHO International Clinical Trials Registry Platform (ICTRP) search portal facilitating African representation in the global picture of planned, ongoing and completed clinical trials. The Registry is currently funded by the European and Developing Countries Clinical Trials Partnership (EDCTP) and coordinated by the South African Cochrane Centre (SACC) at the Medical Research Council (MRC).

General childhood intelligence may be an important and informative early determinant of subsequent adult health

Intelligent children may be less likely to develop serious disease in adulthood than their less intelligent peers, suggests a long term study in the Journal of Epidemiology and Community Health.

FDA approves Cipher's Absorica to treat severe recalcitrant nodular acne

Cipher Pharmaceuticals Inc. announced today that the U.S. Food and Drug Administration (FDA) has approved Absorica, Cipher's novel, patented brand formulation of the acne medication isotretinoin, for the treatment of severe recalcitrant nodular acne.

Read more Medical News

› Verified 2 days ago